Previous 10 | Next 10 |
CHARLOTTESVILLE, Va., March 15, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it will host a Town Hall at 1 P.M.,...
Adial Pharmaceuticals (ADIL) announced the exercise of 712,500 warrants from its June 2020 financing for net proceeds of $1.43M to the company.Press Release For further details see: Adial receives $1.43M in proceeds from warrants exercising
CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced the exerc...
Adial Pharmaceuticals ([[ADIL]] +4.2%) announces that it has reached 50% enrollment in the company’s landmark ONWARD pivotal Phase 3 clinical trial testing AD04 as a therapeutic agent for the treatment of Alcohol Use Disorder ((AUD)).The ONWARD trial is a 24-week, multicenter...
CHARLOTTESVILLE, Va., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) , a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it has reached 50% enrollment in the Company’s land...
CHARLOTTESVILLE, Va., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it w...
Acquisition Expands Adial's Portfolio with Drug Candidates for Treatment of Pain and Addiction CHARLOTTESVILLE, VA / ACCESSWIRE / January 26, 2021 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW) ( "Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on the ...
Adial Pharmaceuticals ([[ADIL]] +4.7%) receives a notice of allowance for its third U.S. patent relating to the use of AD04 for the treatment of opioid use disorder.The patent covers the use of the company's lead product, AD04, as a treatment of opioid use disorder in patients ...
News, Short Squeeze, Breakout and More Instantly...
Adial Pharmaceuticals Inc Company Name:
ADIL Stock Symbol:
NASDAQ Market:
Adial Pharmaceuticals Inc Website:
2024-07-24 06:29:00 ET 3 Top Tips for Building a Penny Stocks Watchlist Investing in penny stocks can offer exciting opportunities for significant returns with a relatively small initial investment. Building a robust penny stocks watchlist is essential for identifying potential winn...
A look at the top 10 most actives in the United States SunPower Corporation (SPWR) rose 31.3% to $0.9396 on volume of 186,118,381 shares Selina Hospitality PLC (SLNA) fell 29.7% to $0.026 on volume of 168,426,091 shares NVIDIA Corporation (NVDA) fell 0.8% to $122.59 on volume of 168,211,0...
A look at the top 10 most actives in the United States Agape ATP Corporation (ATPC) rose 112.1% to $0.3033 on volume of 62,336,784 shares Warrantee Inc. (WRNT) rose 27.8% to $0.372 on volume of 55,635,565 shares Adial Pharmaceuticals Inc (ADIL) rose 110.3% to $2.2295 on volume of 54,549,4...